Friday, June 07, 2019 10:36:54 PM
Jerry Campbell I bet a lot of the holders of 457,000,000 warrants, many with lower strike prices, are willing sellers at current prices.
Neil Woodford is looking to raise some cash.
I bet that ALL of what you are indicating is WRONG just like lots of other previous posts of yours.
1)Warrant holder’s are more likely than not to be to in this for Topline PR for the following reasons:
a)The early Feb Annual Shareholders Meeting of CEO Linda Powers
“coming out from her LONG period of clandestine communiques” followed by:
b) the hiring of David Innes as VP Investor Relations (versus those three to four years ago clamoring for a Chief Financial Officer in which I was the only one to quash the sheer lunacity of that idea for lots of sound reasons posted! AND The Piece de la Resistance:
c)Early in this week posts by DrugRunner; Photonic 5 & Alphapuppy (the latter two relaying of their face to face encounters with Cofer Black, Dr Marnix Bosch, David Innes) ........
ALL of these events since early February, would and should obviate ANY & ALL potential sale of their converted common shares!
2)IF Neil Woodford sold which I deem to be totally ILLOGICAL for the reasonS that:
a)Admission of his own Poor Judgement
b)Meaningless $ at these NWBI price levels(Woodford’s avg cost per share is ~$6.85!) versus the $ value of Woodford’s respective funds
I have yet to see from JerryCampbell in the last few years a correct call: just more of the SAME FUD!
Don’t forget I was a Portfolio Manager vs JerryCampbell(he posted he was a Quant guy)
DIFFERENT STROKES FOR DIFFERENT FOLKS
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
